APPLICATION
ANDA076504
TYPE
ANDA
ORIGINAL APPROVAL
2006-02-22
LATEST ACTION
2019-11-25
ROUTE
NASAL
DOSAGE FORM
SPRAY, METERED
MARKETING STATUS
Prescription
Products
FLUTICASONE PROPIONATEPrescription
FLUTICASONE PROPIONATE 0.05MG/SPRAY · SPRAY, METERED · NASAL
Approval history
2019-11-25Labeling · Supplement 11 · standardAP
2016-02-10Labeling · Supplement 10 · standardAP
2008-07-21Labeling · Supplement 3AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.